If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Patient Focused Services » Patient Advocacy Groups
Download FREE Excerpt
10 Info Graphics
13 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Alliances with patient advocacy groups play an important role in educating the marketplace about new and existing therapies. With the increased need for an effective pharma advocacy function, it has become critical for pharma advocacy groups to evolve and better align their group structure and operations to the overall organizational goals.
Best Practices, LLC conducted this research study to identify the geographic and functional factors that drive advocacy group structure as well as advocacy reporting relationships and how groups align themselves with internal customers. Additionally, this study presents different organizational models for pharma advocacy groups and current trends in staffing and budgets for pharma advocacy groups. Advocacy leaders can use this research to compare their organizational structure and resourcing with those of leading organizations.
SAMPLE KEY FINDING
Functional Drivers of Sub-structure Optimization: Therapeutic area is the dominant factor influencing functional structure evolution. As organizations grow larger and more complex, business units become a significant design factor in helping to organize the mix of product types. With business units in place, lifecycle, economics, and marketplace factors can help guide how intensely Advocacy serves a unit, product, therapeutic issue, partner or region.
Participants in this benchmarking research included executive respondents at 11 leading bio-pharmaceutical and healthcare companies. Field interviews and analysis were conducted to produce valuable research insights and findings. Research participants included Executive Directors, Medical Executives, Directors and Product Managers. More than 80% of benchmark partners were directors or above – and most worked directly in Advocacy groups or functions.
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.